James Ferguson

University Hospitals Birmingham NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

38h-index6.3kcitations208works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease and Transplantation(93), Organ Transplantation Techniques and Outcomes(71), Liver Disease Diagnosis and Treatment(62), Liver Diseases and Immunity(35), Renal Transplantation Outcomes and Treatments(22)

Publications208 total

Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study
Hepatology·2025Open Access
P117 A call for inclusion in addressing variation in UK hospital liver care; a review of national audits, surveys, guidelines and guidance documents from the last five years
2025
P143 A 10-year review of obstetric admissions to a quaternary liver critical care unit: learning from morbidity and mortality
2025
Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis
Alimentary Pharmacology & Therapeutics·2025· 3 citedOpen Access
THU-339-YI UK validation of the simple cholestatic complaints score: a patient reported outcomes measure in primary sclerosing cholangitis
Journal of Hepatology·2025
THU-343 Combination obeticholic acid (OCA) and fibrate therapy is associated with greater probability of biochemical response than switching from OCA to a fibrate in primary biliary cholangitis
Journal of Hepatology·2025
THU-195 Haemophagocytic lymphohistiocytosis – a rare but deadly cause of acute liver failure
Journal of Hepatology·2025
GS-006 A multicentre randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)
Journal of Hepatology·2025· 1 cited
TOP-345-YI A 10-year review of obstetric admissions to a quaternary liver intensive care unit: learning from morbidity and mortality
Journal of Hepatology·2025
Development, Rasch analysis and validation of the kidney symptom burden questionnaire (KSB-Q)
Clinical Kidney Journal·2025Open Access
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (<scp>CALIBRE</scp> Trial)
Alimentary Pharmacology & Therapeutics·2025· 6 citedOpen Access
The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT
Efficacy and Mechanism Evaluation·2025· 1 citedOpen Access
Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression
American Journal of Transplantation·2024· 7 citedOpen Access
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures
Journal of Crohn s and Colitis·2024· 17 citedOpen Access
P70 Evaluating strategies for patient selection in NSBB treatment for chronic advanced compensated liver disease: a comparative study of varices and non-invasive tests
2024
Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based study
The Lancet Regional Health - Europe·2024· 11 citedOpen Access
THU-160 Long-term variability of pruritus in primary sclerosing cholangitis and implications for future clinical trial design
Journal of Hepatology·2024· 1 cited
SAT-483-YI The impact of competing risk bias in prognostic models for hepatocellular carcinoma in patients with cirrhosis
Journal of Hepatology·2024
P342 Pruritus in primary sclerosing cholangitis and implications for clinical trial design
Poster presentations·2024
P316 Small duct primary sclerosing cholangitis is not associated with heightened risk of colorectal cancer compared to inflammatory bowel disease alone
Poster presentations·2024· 1 cited
page 1 of 11Next →

Frequent Co-authors

Paolo Muiesan(10), Joanna Leithead(10), Peter Hayes(9), Bridget Gunson(9), M. Thamara P. R. Perera(8), Darius F. Mirza(8), Déirdre Kelly(7), Philip N. Newsome(7), Andrea Schlegel(7), Gideon M. Hirschfield(7), Dhiraj Tripathi(6), Roger Williams(6), Richard Aspinall(6), Anil Dhawan(6), Graham R. Foster(6), Nick Sheron(6), John Isaac(6), Mark Hudson(5), Matthew Cramp(5), Kieran Moriarty(5)